99 related articles for article (PubMed ID: 8611482)
1. Somatostatin receptor scintigraphy in the initial staging of Hodgkin's disease.
van den Anker-Lugtenburg PJ; Krenning EP; Oei HY; Van Hagen MP; Gerrits CJ; Reubi JC; Lamberts SW; Löwenberg B
Br J Haematol; 1996 Apr; 93(1):96-103. PubMed ID: 8611482
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin receptor scintigraphy useful in stage I-II Hodgkin's disease: more extended disease identified.
Lugtenburg PJ; Krenning EP; Valkema R; Oei HY; Lamberts SW; Eijkemans MJ; van Putten WL; Löwenberg B
Br J Haematol; 2001 Mar; 112(4):936-44. PubMed ID: 11298588
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin receptor scintigraphy in the initial staging of low-grade non-Hodgkin's lymphomas.
Lugtenburg PJ; Löwenberg B; Valkema R; Oei HY; Lamberts SW; Eijkemans MJ; van Putten WL; Krenning EP
J Nucl Med; 2001 Feb; 42(2):222-9. PubMed ID: 11216520
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin receptor scintigraphy in cutaneous malignant lymphomas.
van den Anker-Lugtenburg PJ; Heule F; Vanhagen PM; van Joost T; Oei HY; Löwenberg B; Krenning EP
J Am Acad Dermatol; 1996 Jun; 34(6):985-93. PubMed ID: 8647992
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin analogue scintigraphy of malignant lymphomas.
Vanhagen PM; Krenning EP; Reubi JC; Mulder AH; Bakker WH; Oei HY; Löwenberg B; Lamberts SW
Br J Haematol; 1993 Jan; 83(1):75-9. PubMed ID: 8094627
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin receptor scintigraphy in the staging of lymphomas.
Ivancević V; Wörmann B; Nauck C; Sandrock D; Munz DL; Hiddemann W; Emrich D
Leuk Lymphoma; 1997 Jun; 26(1-2):107-14. PubMed ID: 9250794
[TBL] [Abstract][Full Text] [Related]
7. Indium-111 pentetreotide scintigraphy in malignant lymphomas.
Sarda L; Duet M; Zini JM; Berolatti B; Benelhadj S; Tobelem G; Mundler O
Eur J Nucl Med; 1995 Oct; 22(10):1105-9. PubMed ID: 8542892
[TBL] [Abstract][Full Text] [Related]
8. Radiolabeled octreotide for the demonstration of somatostatin receptors in malignant lymphoma and lymphadenopathy.
Lipp RW; Silly H; Ranner G; Dobnig H; Passath A; Leb G; Krejs GJ
J Nucl Med; 1995 Jan; 36(1):13-8. PubMed ID: 7799065
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin-receptor scintigraphy in primary breast cancer.
van Eijck CH; Krenning EP; Bootsma A; Oei HY; van Pel R; Lindemans J; Jeekel J; Reubi JC; Lamberts SW
Lancet; 1994 Mar; 343(8898):640-3. PubMed ID: 7906813
[TBL] [Abstract][Full Text] [Related]
10. The relevance of somatostatin receptor expression in malignant lymphomas.
van den Anker-Lugtenburg PJ; Löwenberg B; Lamberts SW; Krenning EP
Metabolism; 1996 Aug; 45(8 Suppl 1):96-7. PubMed ID: 8769395
[TBL] [Abstract][Full Text] [Related]
11. Ultrasound examination of pathological cervical lymph nodes in patients with non-Hodgkin's lymphoma and Hodgkin's disease.
Gerrits CJ; van Overhagen H; van Lom K; Adriaansen HJ; Löwenberg B
Br J Haematol; 1994 Nov; 88(3):626-8. PubMed ID: 7819079
[TBL] [Abstract][Full Text] [Related]
12. Somatostatin-receptor scintigraphy for staging and follow-up of patients with extraintestinal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT)-type.
Raderer M; Traub T; Formanek M; Virgolini I; Osterreicher C; Fiebiger W; Penz M; Jäger U; Pont J; Chott A; Kurtaran A
Br J Cancer; 2001 Nov; 85(10):1462-6. PubMed ID: 11720429
[TBL] [Abstract][Full Text] [Related]
13. Gallium scan in adolescents and children with Hodgkin's disease (HD). Treatment response assessment and prognostic value.
Castellani MR; Cefalo G; Terenziani M; Aliberti G; Maccauro M; Alessi A; Villano C; Bombardieri E
Q J Nucl Med; 2003 Mar; 47(1):22-30. PubMed ID: 12714951
[TBL] [Abstract][Full Text] [Related]
14. Comparison of 18F-fluoro-2-deoxyglucose positron emission tomography and gallium-67 citrate scintigraphy for detecting malignant lymphoma.
Shen YY; Kao A; Yen RF
Oncol Rep; 2002; 9(2):321-5. PubMed ID: 11836600
[TBL] [Abstract][Full Text] [Related]
15. Hodgkin's disease: internal mammary lymph nodes relapse diagnosed by gallium-67 scintigraphy.
Ruíz Hernández G; Pallardó Y; García Conde J; Ramos D; Ampudia J; Castillo FJ; Romero C
Nuklearmedizin; 1999 Apr; 38(3):90-4. PubMed ID: 10320995
[TBL] [Abstract][Full Text] [Related]
16. Specificity of somatostatin receptor scintigraphy: a prospective study and effects of false-positive localizations on management in patients with gastrinomas.
Gibril F; Reynolds JC; Chen CC; Yu F; Goebel SU; Serrano J; Doppman JL; Jensen RT
J Nucl Med; 1999 Apr; 40(4):539-53. PubMed ID: 10210211
[TBL] [Abstract][Full Text] [Related]
17. Technetium-99m depreotide imaging by single photon emission tomography/low resolution computed tomography in malignant lymphomas: comparison with gallium-67 citrate.
Apostolopoulos DJ; Papandrianos NI; Symeonidis A; Spyridonidis T; Alexiou S; Zampakis P; Savvopoulos C; Vassilakos PJ; Matsouka P
Ann Nucl Med; 2010 Nov; 24(9):639-47. PubMed ID: 20799079
[TBL] [Abstract][Full Text] [Related]
18. [Ga-67 scintigraphy for the localization and staging of malignant lymphoma].
Monzawa S; Karikomi M; Uno K; Itami J; Arimizu N
Gan No Rinsho; 1988 Aug; 34(9):1059-64. PubMed ID: 3172511
[TBL] [Abstract][Full Text] [Related]
19. Routine bone scintigraphy is of limited value in the clinical assessment of untreated patients with Hodgkin's disease.
Landgren O; Axdorph U; Jacobsson H; Johansson B; Grimfors G; Björkholm M
Med Oncol; 2000 Aug; 17(3):174-8. PubMed ID: 10962526
[TBL] [Abstract][Full Text] [Related]
20. Initial staging of lymphoma with octreotide and other receptor imaging agents.
Ferone D; Semino C; Boschetti M; Cascini GL; Minuto F; Lastoria S
Semin Nucl Med; 2005 Jul; 35(3):176-85. PubMed ID: 16098291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
